Entourage Updates Timing of Fiscal Year 2021 Financial Results Call to May 3, 2022
22 avr. 2022 08h02 HE
|
Entourage Health Corp.
Company reaffirms preliminary fiscal year 2021 record revenue of $54.8 million(1)Results to be filed after-market May 2, 2022, with management hosting a call on following day TORONTO, April 22, 2022...
Entourage Health Debuts New 2022 Color Cannabis Branding Campaign and Celebrates All-Female-Led Marketing and Promotions Team
08 mars 2022 09h37 HE
|
Entourage Health Corp.
TORONTO, March 08, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of...
Entourage Health and LiUNA Pension Fund Upsize Credit Facility with Additional $20 Million in Non-Dilutive Financing
24 déc. 2021 12h18 HE
|
Entourage Health Corp.
TORONTO, Dec. 24, 2021 (GLOBE NEWSWIRE) -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of...
Entourage Health Launches Cannabis-Infused Soft Chews for Starseed Medicinal Line
29 nov. 2021 08h30 HE
|
Entourage Health Corp.
TORONTO, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of...
Entourage Health Launches Mary’s Medicinals Transdermal Cannabis Patches in Canada
16 sept. 2021 08h57 HE
|
Entourage Health Corp.
Innovative suite of Mary’s line-up produced locally now includes Transdermal Patches in CBD, THC and 1:1 formulations that offer a novel, alternative path to cannabinoid deliveryWith over 40 medical...
WeedMD to Host Fiscal Year End 2020 Conference Call on May 31st
21 mai 2021 08h18 HE
|
WeedMD Rx Inc.
Company financials to be filed after market on May 28, 2021 and operational outlook to be provided during call, including first quarter 2021 record milestones achieved TORONTO, May 21, 2021 (GLOBE...
WeedMD to Host Fiscal Year-End 2020 Conference Call on April 30, 2021
09 avr. 2021 09h02 HE
|
WeedMD Rx Inc.
TORONTO, April 09, 2021 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally licensed producer and distributor of medical-grade cannabis,...
WeedMD’s Color Cannabis Expands Product Portfolio with Debut of Live Resin in Pedro’s Sweet Sativa Cultivar
25 mars 2021 08h00 HE
|
WeedMD Rx Inc.
TORONTO, March 25, 2021 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally licensed producer and distributor of medical-grade cannabis, is...
WeedMD Announces Mary’s Medicinals Topicals Product Release in Canada
16 févr. 2021 08h26 HE
|
WeedMD Rx Inc.
Acclaimed Mary’s Medicinals Transdermal Compound, produced exclusively in Canada by WeedMD, with expected availability to Starseed Medicinal’s patients starting late February, 2021Mary’s Medicinals...
WeedMD Announces the Development of New Cannabis 2.0 Products Featuring Hash, Live Resin and Rosin Extracts for Adult-Use Lineup
19 janv. 2021 08h06 HE
|
WeedMD Rx Inc.
TORONTO, Jan. 19, 2021 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally licensed producer and distributor of medical-grade cannabis, is...